4.8 Article

Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes

Andrea Arena et al.

Summary: Autoimmune endocrine disorders such as type 1 diabetes and thyroiditis currently rely on hormone replacement therapy, highlighting the need for personalized immunotherapeutic strategies targeting T and B lymphocytes. This study improved upon a personalized immunotherapeutic approach by functionalizing liposomes with Rituximab antibody, specifically targeting B lymphocytes in conditions like type 1 diabetes. The results showed that these functionalized liposomes had a significant inhibitory effect on the function of B lymphocytes, suggesting potential applicability for personalized immunotherapy in other autoimmune disorders where B lymphocytes are the primary pathogenic immune cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Medicine, General & Internal

Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers

Chia-Hsueh Lin et al.

Summary: Siglecs are a family of Ig-like lectins, with different types delivering inhibitory signals or cell activation signals. The number of Siglec-encoding genes is correlated to mammal lifespan, while certain polymorphisms of Siglecs are associated with various diseases.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)

Review Biochemistry & Molecular Biology

Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments

Elena Gianchecchi et al.

Summary: Siglecs are a type of sialic acid-binding immunoglobulin-like lectins that play a crucial role in regulating immune responses. They play a key role in distinguishing between self and non-self molecules.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Siglec-10 expression is up-regulated in activated human CD4+ T cells

E. Bandala-Sanchez et al.

HUMAN IMMUNOLOGY (2020)

Review Endocrinology & Metabolism

Type 1 diabetes-early life origins and changing epidemiology

Jill M. Norris et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Review Biochemistry & Molecular Biology

Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview

Novella Rapini et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemistry & Molecular Biology

Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance

Jason Gaglia et al.

BIOCHEMISTRY (2019)

Article Immunology

Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52

Abdulrahman M. Shathili et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Endocrinology & Metabolism

Autoimmune polyglandular diseases

George J. Kahaly et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Multidisciplinary Sciences

CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function

Esther Bandala-Sanchez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Endocrinology & Metabolism

Association of obesity and diabetes with thyroid nodules

Silvio Buscemi et al.

ENDOCRINE (2018)

Article Biochemistry & Molecular Biology

CTLA-4+49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis

Ke Wang et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2017)

Review Cell Biology

The immunological function of CD52 and its targeting in organ transplantation

Yang Zhao et al.

INFLAMMATION RESEARCH (2017)

Review Biochemistry & Molecular Biology

Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis

Christian Bull et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Review Biotechnology & Applied Microbiology

Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents

Aleksandra Krzewska et al.

BIOMED RESEARCH INTERNATIONAL (2016)

Review Rheumatology

The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease

Jennifer Mueller et al.

NATURE REVIEWS RHEUMATOLOGY (2014)

Editorial Material Endocrinology & Metabolism

Improving diabetes care in resource-poor countries: challenges and opportunities

Mark A. Atkinson et al.

LANCET DIABETES & ENDOCRINOLOGY (2013)

Article Chemistry, Multidisciplinary

Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting

Cory D. Rillahan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)

Article Immunology

PTPN22 Alters the Development of Regulatory T Cells in the Thymus

Christian J. Maine et al.

JOURNAL OF IMMUNOLOGY (2012)

Article Endocrinology & Metabolism

Genetics of the Autoimmune Polyglandular Syndrome Type 3 Variant

Manuela Dittmar et al.

THYROID (2010)

Review Immunology

Siglecs and their roles in the immune system

Paul R. Crocker et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Chemistry, Multidisciplinary

Role of the spacer stereochemistry on the aggregation properties of cationic gemini surfactants

Cristiano Bello et al.

LANGMUIR (2006)

Review Surgery

LFA-1 (CD11a) as a therapeutic target

MR Nicolls et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2006)